In addition, enhanced expression of Arf6 is observed in breast cancer cells, and GEP100 (also known as BRAG2), an activator for Arf6, is responsible for the invasive activity of MDA-MB-231 breast cancer cells [106]. This evidence concerns the gene ARF6 and breast carcinoma.